MAUDE Adverse Event Report: PFIZER CONSUMER HEALTH CARE THERMACARE MUSCLE & JOINT; DISPOSABLE PACK, HOT

Lot Number T26686

Device Problems Break (1069); Fluid/Blood Leak (1250); Nonstandard Device (1420)

Patient Problem No Known Impact Or Consequence To Patient (2692)

Event Type  malfunction  

Manufacturer Narrative

The root cause category is non assignable (complaint not confirmed).The return sample is not available from consumer for evaluation the complaint can not be confirmed.Our manufacturing operations employ quality control procedures which include in process testing, and visual inspection, to ensure the quality of the product being packaged.No quality issues were identified upon this review of batch records, release testing data or, inspection of retained samples.Retained samples met the product description and the product is within expiration date.Investigation (b)(4) t26691, t26693, t26686 & s68516 menstrual & muscle joint us cells damaged/leaking was conducted for the same sub-class.This batch t26691 was reviewed at aqrt and the outcome determination was to recall the four batches (t26691, t26693, and t26686 & s68516) per investigation (b)(4).

Event Description

Event verbatim [preferred term] i threw the package away because they were leaking [device leakage].Case narrative: this is a spontaneous report from a contactable consumer.This male consumer of unknown age started to receive thermacare heatwrap (thermacare muscle & joint) lot number t26686, expiration date jul2020, from unknown date for unknown indication.Medical history and concomitant medications were not reported.Consumer wanted reimbursement on the heatwraps that's on recall.He bought 2 menstrual pain therapy 8hr and 1 muscle pain therapy 8hr.He i threw the package away because they were leaking.They were the ones on recall.The action taken in response to the event of the product was unknown.The outcome of the event was unknown.According to product quality complaint group: the root cause category is non assignable (complaint not confirmed).The return sample is not available from consumer for evaluation the complaint can not be confirmed.Our manufacturing operations employ quality control procedures which include in process testing, and visual inspection, to ensure the quality of the product being packaged.No quality issues were identified upon this review of batch records, release testing data or, inspection of retained samples.Retained samples met the product description and the product is within expiration date.Investigation (b)(4) t26691, t26693, t26686 & s68516 menstrual & muscle joint us cells damaged/leaking was conducted for the same sub-class.This batch t26686 was reviewed at aqrt and the outcome determination was to recall the four batches (t26691, t26693, and t26686 & s68516) per investigation (b)(4).Company clinical evaluation comment: the above referenced lot number t26686 was recalled on 02-oct-2018.Subsequent to the conclusion of a manufacturing investigation, (b)(4) initiated a voluntary recall of 6 lots [s68516, t26686, t26691, t26693, 8054ha, 8054hb] due to a potential for device leakage of the ingredients contained in the heat wrap that could result in serious skin-related events, including burn.These 6 lots were distributed in the united states with expiry dates of either july or august 2020.

Manufacturer Narrative

The root cause category is non assignable (complaint not confirmed).The return sample is not available from consumer for evaluation the complaint can not be confirmed.Our manufacturing operations employ quality control procedures which include in process testing, and visual inspection, to ensure the quality of the product being packaged.No quality issues were identified upon this review of batch records, release testing data or, inspection of retained samples.Retained samples met the product description and the product is within expiration date.Investigation pr (b)(4) menstrual & muscle joint us cells damaged/leaking was conducted for the same sub-class.This batch t26691 was reviewed at aqrt and the outcome determination was to recall the four batches (t26691, t26693, and t26686 & s68516) per investigation pr (b)(4).

Event Description

Event verbatim [preferred term] i threw the package away because they were leaking [device leakage].Case narrative: this is a spontaneous report from a contactable consumer.This male consumer of unknown age started to receive thermacare heatwrap (thermacare muscle & joint) lot number t26686, expiration date jul2020, lot number t26691, expiration date jul2020, from unknown date for unknown indication.Medical history and concomitant medications were not reported.Consumer wanted reimbursement on the heatwraps that's on recall.He bought 2 menstrual pain therapy 8hr and 1 muscle pain therapy 8hr.He i threw the package away because they were leaking.They were the ones on recall.The action taken in response to the event of the product was unknown.The outcome of the event was unknown.According to product quality complaint group: the root cause category is non assignable (complaint not confirmed).The return sample is not available from consumer for evaluation the complaint can not be confirmed.Our manufacturing operations employ quality control procedures which include in process testing, and visual inspection, to ensure the quality of the product being packaged.No quality issues were identified upon this review of batch records, release testing data or, inspection of retained samples.Retained samples met the product description and the product is within expiration date.Investigation pr (b)(4) menstrual & muscle joint us cells damaged/leaking was conducted for the same sub-class.This batch t26686 was reviewed at aqrt and the outcome determination was to recall the four batches (t26691, t26693, and t26686 & s68516) per investigation pr (b)(4).Amendment: this follow-up report is being submitted to amend previously reported information: lot number t26691 was added.Company clinical evaluation comment: the above referenced lot numbers t26686 and t26691 were recalled on (b)(6) 2018.Subsequent to the conclusion of a manufacturing investigation, pfizer initiated a voluntary recall of 6 lots [s68516, t26686, t26691, t26693, 8054ha, 8054hb] due to a potential for device leakage of the ingredients contained in the heat wrap that could result in serious skin-related events, including burn.These 6 lots were distributed in the united states with expiry dates of either july or august 2020., comment: the above referenced lot numbers t26686 and t26691 were recalled on 02oct2018.Subsequent to the conclusion of a manufacturing investigation, pfizer initiated a voluntary recall of 6 lots [s68516, t26686, t26691, t26693, 8054ha, 8054hb] due to a potential for device leakage of the ingredients contained in the heat wrap that could result in serious skin-related events, including burn.These 6 lots were distributed in the united states with expiry dates of either july or august 2020.

Event Description

Event verbatim [preferred term] i threw the package away because they were leaking [device leakage] ,.Case narrative:this is a spontaneous report from a contactable consumer.This male consumer of unknown age started to receive thermacare heatwrap (thermacare muscle & joint) lot number t26686, expiration date jul2020, from unknown date for unknown indication.Medical history and concomitant medications were not reported.Consumer wanted reimbursement on the heatwraps that's on recall.He bought 2 menstrual pain therapy 8hr and 1 muscle pain therapy 8hr.He i threw the package away because they were leaking.They were the ones on recall.The action taken in response to the event of the product was unknown.The outcome of the event was unknown.According to product quality complaint group: the root cause category is non assignable (complaint not confirmed).The return sample is not available from consumer for evaluation the complaint can not be confirmed.Our manufacturing operations employ quality control procedures which include in process testing, and visual inspection, to ensure the quality of the product being packaged.No quality issues were identified upon this review of batch records, release testing data or, inspection of retained samples.Retained samples met the product description and the product is within expiration date.Investigation pr 2379610 t26691, t26693, t26686 & s68516 menstrual & muscle joint us cells damaged/leaking was conducted for the same sub-class.This batch t26686 was reviewed at aqrt and the outcome determination was to recall the four batches (t26691, t26693, and t26686 & s68516) per investigation pr 2379610.Amendment: this follow-up report is being submitted to amend previously reported information: lot number t26691 was added.Amendment: this follow-up report is being submitted to amend previously reported information: lot number t26691 was removed.Company clinical evaluation comment: the above referenced lot numbers t26686 were recalled on 02oct2018.Subsequent to the conclusion of a manufacturing investigation, pfizer initiated a voluntary recall of 6 lots [s68516, t26686, t26691, t26693, 8054ha, 8054hb] due to a potential for device leakage of the ingredients contained in the heat wrap that could result in serious skin-related events, including burn.These 6 lots were distributed in the united states with expiry dates of either july or august 2020., comment: the above referenced lot numbers t26686 were recalled on 02oct2018.Subsequent to the conclusion of a manufacturing investigation, pfizer initiated a voluntary recall of 6 lots [s68516, t26686, t26691, t26693, 8054ha, 8054hb] due to a potential for device leakage of the ingredients contained in the heat wrap that could result in serious skin-related events, including burn.These 6 lots were distributed in the united states with expiry dates of either july or august 2020.

Manufacturer Narrative

The root cause category is non assignable (complaint not confirmed).The return sample is not available from consumer for evaluation the complaint can not be confirmed.Our manufacturing operations employ quality control procedures which include in process testing, and visual inspection, to ensure the quality of the product being packaged.No quality issues were identified upon this review of batch records, release testing data or, inspection of retained samples.Retained samples met the product description and the product is within expiration date.Investigation pr 2379610 t26691, t26693, t26686 & s68516 menstrual & muscle joint us cells damaged/leaking was conducted for the same sub-class.This batch t26691 was reviewed at aqrt and the outcome determination was to recall the four batches (t26691, t26693, and t26686 & s68516) per investigation pr 2379610.

• Brand Name: THERMACARE MUSCLE & JOINT
• Type of Device: DISPOSABLE PACK, HOT
• Manufacturer (Section D): PFIZER CONSUMER HEALTH CARE; 1231 wyandotte drive; albany GA 31705
• MDR Report Key: 8273632
• MDR Text Key: 136140899
• Report Number: 1066015-2019-00017
• Device Sequence Number: 1
• Product Code: IMD
• Combination Product (y/n): N
• PMA/PMN Number: K953442
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Manufacturer
• Source Type: consumer
• Remedial Action: Recall
• Type of Report: Initial,Followup,Followup
• Report Date: 01/08/2019

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Date FDA Received: 01/24/2019
• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: Yes
• Device Operator: Lay User/Patient
• Device Expiration Date: 07/01/2020
• Device Lot Number: T26686
• Was Device Available for Evaluation?: No
• Is This a Reprocessed and Reused Single-Use Device?: No
• Patient Sequence Number: 1